Drug intelligence / Profile preview

Magnidicon

Development stage
Unknown
Lead developer
PT Tunggal Idaman Abadi
Modality
Small Molecules
Administration
Oral
01

Overview

Magnidicon is an oral antacid and antiflatulent combination therapy developed and manufactured by Tunggal Idaman Abdi. It is formulated as both a chewable tablet and an oral suspension containing aluminium hydroxide, magnesium hydroxide, and simethicone. Aluminium hydroxide and magnesium hydroxide act as antacids by neutralizing gastric acid, thereby reducing hyperacidity and relieving symptoms of gastritis, peptic ulcers, and gastric distress. Simethicone is a surfactant that reduces the surface tension of gas bubbles in the gastrointestinal tract, facilitating their coalescence and expulsion to relieve bloating and flatulence. Magnidicon is approved and marketed in Indonesia for the symptomatic relief of gastric hyperacidity, gastritis, duodenal ulcers, flatulence, and bloating.

Brand names
MagnidiconMagnidicon SuspensionMagnidicon Tablet
Other names
aluminium hydroxide + magnesium hydroxide + simethiconealuminum hydroxide + magnesium hydroxide + simethicone

Beyond the preview

Go deeper on Magnidicon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnidicon.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call